cagrilintide trial Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 Weight Loss Efficacy of Cagrilintide

BPC-157 research focuses on angiogenesis and growth-factor pathways and includes a broad gastrointestinal record, while TB-500 research focuses on actin regulation and cell migration

Its anti-inflammatory properties also dampen pro-inflammatory cytokines, helping with conditions like seborrheic dermatitis or alopecia areata

A lab coat is always a good idea

A systematic review published in 2025 identified 544 total articles on BPC-157 published between 1993 and 2024, filtering to 36 studies meeting inclusion criteria

Integrate with a Comprehensive IBS Management Plan BPC-157 should be used as part of a broader IBS management plan that includes dietary adjustments, stress management, and possibly other treatments as recommended by your healthcare provider